廈鎢新能(688778.SH):擬設立合資公司建設雅安基地年產100,000噸磷酸鐵鋰項目(一期)
格隆匯12月14日丨廈鎢新能(688778.SH)公佈,公司擬與雅化鋰業(雅安)有限公司(“雅化鋰業”)以及廈門滄雅投資合夥企業(有限合夥)(“滄雅投資”)在四川省雅安市經濟技術開發區合資設立雅安廈鎢新能源材料有限公司(暫定名,簡稱“雅安廈鎢新能”或“合資公司”,最終以市場監督管理局登記核准為準),分期投資建設年產100,000噸磷酸鐵鋰生產線,其中首期建設20,000噸磷酸鐵鋰生產線。
合資公司註冊資本為 5億元人民幣,經營地址為四川省雅安市經濟技術開發區。
公司計劃總投資9.27億元(最終投資總額以實際投資為準)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.